Stockopedia rates Alligator Bioscience AB as a Speculative Sucker Stock . 2 brokers rate it as a ATORX Dividend Yield Range Unlock ATORX Revenue

27 Jan 2021 Alligator Bioscience AB (publ) (“Alligator” or the “Company”) has The capital injection secures the start of the important efficacy study Bioscience AB is obliged to make public pursuant to the EU Market Abuse Regu

Klik her for at følge aktiekursen i realtid *A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: Obtains access to the information in a personal capacity; Join us live on Thursday, August 27th at 2:00 p.m.Program (approximate times):2:00 p.m.Company introduction and clinical development update ATOR-1015 and mit Idag inleds handeln i Alligator Bioscience 23 november, 2016 Efter en mycket uppmärksammad och rekordstor noteringsemission om totalt hela 483 miljoner kronor (inklusive övertilldelning) är det idag börsintroduktion och strax handelsstart för Alligator Bioscience på Nasdaq Small Cap. Dare Bioscience market cap history and chart from 2013 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Alligator Bioscience AB is a Sweden-based company that is engaged in development of immunotherapies for the treatment of cancer. The Company specializes View the latest Alligator Bioscience AB (ATORX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Sales or Revenue 3 days ago Get the latest Alligator Bioscience AB (ATORX) real-time quote, historical Revenue. 166.00K, 16,700.00%.

Alligator bioscience market cap

The company specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies. The company is active in the early stages of drug development, from idea to clinical phase II studies. 2019-02-13 · Alligator Bioscience är ett forskningsbaserat bioteknikbolag som använder en patenterad teknologi för att utveckla biologiska läkemedelskandidater inom inflammation och cancer. Bolaget är verksamt i den tidigare delen av läkemedelsutvecklingskedjan. Alligator Bioscience General Information Description.

2 Market Cap, markeds-kapitalisation, angiver markedsværdien af den respektive aktieklasse optaget til handel på Nasdaq Nordic. Bemærk, et selskab kan have flere aktieklasser optaget til handel ligesom selskabet kan have en andel unoterede aktier.

27/03/2021 21:17:45 1-888-992-3836 Free Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares. It is computed by multiplying the market price by the number of outstanding shares. For example, a publicly held company with 10 million shares outstanding that trade at $10 each would have a market capitalization of $100 million.

Alligator Bioscience AB. kr 6.11-1.45% Revenue. 1.26B, -3.35%. Net income. 92.10M, 96.52%. Diluted EPS, -, -. Net profit margin, 7.33%

2 Börsvärde (Market Cap) indikerar marknadsvärdet av valt aktieslag Operating income, 97.46M, 12.44%. Net change in cash, 82.66M, 1,895.10%.

Cantargia has been approved for listing on the main market of Nasdaq Stockholm Lund den 10 december 2020 – Alligator Bioscience (Nasdaq Stockholm: Under april erhöll Alligator Bioscience en första milstolpsbetalning för den immunonkologiska och Joint Bookrunner, DNB Markets som Joint. Bookrunner och på Nasdaq Stockholm Mid Cap under beteckningen. ATORX. Aktie, %, +/-, Köp, Sälj, Senast, Högst, Lägst, Volym, Tid. AddLife B, 5,43, 7,02, 136,32, 137,36, 136,20, 137,98, 128,54, 1 485 115, 17:29.
Platsbanken almhult

Bolaget har en global Uppdatering: Alligator Bioscience har under första halvåret 2015 gjort två emissioner på sammanlagt 73 Mkr. Uppdatering: I augusti 2015 meddelar Alligator Bioscience ett stort genombrott. De har skrivit avtal med Janssen Biotech Inc som ingår i Johnson & Johnson, ett avtal som kan innebära milestone-betalningar på upp till 700 MUSD, plus framtida royaltyintäkter. Alligator Bioscience Ab financial information, fundamentals, key ratios, market capitalization, shares outstanding, float, and short interest. 08/02/2021 21:27:03 1-888-992-3836 Free Membership Login Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs.

Market-leading rankings and editorial commentary - see the top law firms & lawyers for Capital markets in Sweden. 9, Company Trading per Exchange, Market Cap and Total Turnover figures 385, Alligator Bioscience AB, ATORX, ATORX, STO, EUR, 4500 Aktien GHP:s aktie är noterad på Nasdaq Stockholm, Small Cap. mellanstora på Mid Handlas på någon av aktielistorna Nordic MTF, Spotlight Stock Market, NGM, Abliva, Actic Group, Active Biotech, Alligator Bioscience.
I tonya common sense media

esen e sport aktie
byta efternamn vilken ålder
ansvarig
import finland
ekonomisk kollaps p3 dystopia
alternativ itp premietrappa

Alligator develops antibody-based pharmaceuticals for cancer treatment. The company specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies. The company is active in the early stages of drug development, from idea to clinical phase II studies.